Pharmaceuticals, Biotechnology and Life Sciences
WARREN, N.J., Oct. 22, 2024 (GLOBE NEWSWIRE) — Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage…
BERWYN, Pa., Oct. 22, 2024 (GLOBE NEWSWIRE) — AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical…
TEMPE, Ariz., Oct. 21, 2024 (GLOBE NEWSWIRE) — OnePoint Patient Care (“OPPC”) announced today that it is notifying individuals whose information…
Enhanced protection of vision with ANX007 treatment in healthier eyes Greater preservation of EZ in the central fovea by ANX007…
LA JOLLA, CA, Oct. 21, 2024 (GLOBE NEWSWIRE) — GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a…
SAN DIEGO, Oct. 21, 2024 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report third quarter…
CAMBRIDGE, Mass. and VANCOUVER, British Columbia and BASEL, Switzerland, Oct. 21, 2024 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a…
ROCKVILLE, Md., Oct. 21, 2024 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and…
REDWOOD CITY, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted…
Deadline to submit nominations is January 31, 2025WALTHAM, Mass., Oct. 21, 2024 (GLOBE NEWSWIRE) — Ardelyx, Inc. (Nasdaq: ARDX), a…